Financial Performance - The company's operating revenue for Q1 2023 was ¥314,660,585.53, a decrease of 14.55% compared to ¥368,222,200.19 in the same period last year[8] - Net profit attributable to shareholders was ¥135,016,606.20, down 12.57% from ¥154,426,668.50 year-on-year[8] - Basic earnings per share decreased to ¥0.41, down 12.77% from ¥0.47 in the same period last year[8] - Net profit for Q1 2023 was CNY 158,584,575.15, a decrease of 13.3% compared to CNY 182,931,915.11 in Q1 2022[34] Cash Flow - The net cash flow from operating activities improved significantly to ¥7,833,366.33, compared to a negative cash flow of ¥177,363,851.91 in the previous year, marking a 104.42% increase[8] - Cash flow from operating activities in Q1 2023 was CNY 151,233,974.85, significantly up from CNY 73,804,187.13 in the previous year[35] - Net cash outflow from operating activities was $169.06 million, down from $261.47 million, showing improved cash management[41] - The net increase in cash and cash equivalents was negative at $35.10 million, compared to a negative $201.88 million previously, suggesting improved liquidity management[41] Assets and Liabilities - Total assets increased by 5.28% to ¥4,411,079,031.35 from ¥4,190,016,000.83 at the end of the previous year[8] - The company's total liabilities decreased by 12.71% for notes payable, amounting to ¥77,283,182.10[13] - The total current assets are 3,487,532,931.40 RMB, up from 3,282,827,010.25 RMB, indicating an increase of about 6.25%[23] - The total liabilities as of March 31, 2023, were CNY 684,292,816.27, an increase from CNY 621,639,915.58 at the beginning of the year[33] Research and Development - Research and development expenses increased by 107.74% to ¥20,419,779.98, reflecting an increase in R&D projects[13] - Research and development expenses for Q1 2023 were CNY 20,419,779.98, an increase of 108.5% compared to CNY 9,829,703.79 in the same period last year[34] Shareholder Information - The total number of common shareholders at the end of the reporting period is 35,628[21] - The total equity attributable to shareholders of the parent company reached CNY 3,096,541,874.32, up from CNY 2,961,699,713.44 at the start of the year[33] Future Outlook - The company expects net profit attributable to shareholders for the first half of 2023 to be approximately ¥241,819,200, representing a growth of 15.00% compared to ¥210,277,600 in the same period last year[19] - The company anticipates a positive performance outlook, with earnings expected to rise in the upcoming periods[22]
北摩高科(002985) - 2023 Q1 - 季度财报